NEW YORK (GenomeWeb) – NantHealth disclosed Friday after the close of the market that it has received a delisting notice from the Nasdaq Stock Market because its stock price has been below $1 for at least 30 consecutive business days.

The company disclosed this news in a filing with the Securities and Exchange Commission just ahead of the long holiday weekend in the US, though NantHealth said it received the delisting notice two days earlier.